CYP2J2 and heart disorder: Our data indicated that newly detected CYP2J2 variants might have impacts to the metabolism of clinically used CYP2J2-mediated drugs or influence the development of several diseases, especially cardiac disease, especially for the carriers with mutations that showed both extremely low protein expression ability and low metabolic activity.